WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Is it the beginning of the end or the end of the beginning for Gilead? Here's why we were so obsessed with The Handmaid's ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

June Osborne (Elisabeth Moss) hasn’t worn the crimson uniform on The Handmaid’s Tale since season 4, and it seemed unlikely ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

Maertens reported relationships with F2G, Cidara, Pfizer, Gilead, MSD, Takeda, Mundipharma, Basilea, and Shionogi. Co-authors ...

These four BofA Securities Growth 10 stocks come with reliable dividends and are are timely ideas for growth and income ...

After six seasons of horrific state-sanctioned violence, The Handmaid’s Tale viewers were widely hoping for a bloodbath uprising at Serena Joy’s wedding. HBO has form for it, after all, with the Game ...